ipriflavone has been researched along with CKD-MBD in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hyodo, T | 1 |
| Ono, K | 1 |
| Koumi, T | 1 |
| Miyagawa, I | 1 |
| Okano, T | 1 |
| Kagawa, T | 1 |
| Hagino, H | 1 |
| Kishimoto, H | 1 |
| Oyama, Y | 1 |
| Inoue, A | 1 |
1 other study available for ipriflavone and CKD-MBD
| Article | Year |
|---|---|
A study of the effects of ipriflavone administration on hemodialysis patients with renal osteodystrophy: preliminary report.
Topics: Alkaline Phosphatase; Calcitonin; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Isoflavo | 1991 |